Hydration Pharmaceuticals Co Ltd
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company.
The business
The Hydration Pharmaceuticals Company Limited is an Australia-based hydration solutions company. The Company is focused on the sale and distribution of Hydralyte, which includes a product range of electrolyte-rich tablets, liquids, and powders. The Company markets and sells a range of liquid, tablet, and powder healthy hydration solutions products in the North American markets of Canada and the United States, under the Hydralyte brand. The Company operates as a wholesale supplier and online retailer of Hydralyte products in North America. The Company has a sales footprint in various markets, including the United States, Canada, Australia, New Zealand, Asia (excluding China, which includes Hong Kong but excludes Taiwan), Africa and the Middle East (excluding Turkey). Its subsidiaries include Hydration Pharmaceuticals Trust, Hydration Pharmaceuticals Canada, Hydralyte LLC, and others.
Small Caps Research
No research on Hydration Pharmaceuticals Co Ltd yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise HPC based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Performance
Latest news

Hydralyte North America reaches sales milestone on Amazon USA, Canadian market penetration surges
As part of its ongoing US expansion, The Hydration Pharmaceuticals Company (ASX: HPC), which trades as Hydralyte North America, has achieved a major sales milestone on Amazon USA, while revenue growth in Canada has surged in recent weeks. Hydralyte North America has developed and sells a range of Hydralyte products, which it describes as “healthy […]

Hydralyte North America launches Shay Mitchell co-branded rehydration product
The Hydration Pharmaceuticals Company (ASX: HPC) trading as Hydralyte North America has successfully launched a co-branded rehydration product with renowned actress Shay Mitchell. Ms Mitchell was engaged as Hydralyte North America’s brand ambassador in March this year and today’s co-branded stockkeeping unit (SKU) product launch follows an “extensive period of collaboration”. The collaboration involved flavour […]

Hydralyte North America gains regulatory approvals for Canadian market
The Hydration Pharmaceuticals Company Limited (ASX: HPC) (trading as Hydralyte North America) has secured regulatory approvals from Health Canada for the manufacture of liquid products destined for the Canadian market. The approvals will allow the company to optimise its manufacturing processes from a centralised hub and capitalise on its existing distribution channels across North America. […]

Hydralyte North America reports strong quarterly sales fuelled by Canadian heatwave
A net sales revenue of US$2.44 million has delivered another quarter of strong growth for The Hydration Pharmaceuticals Company (ASX: HPC), trading as Hydralyte North America. Revenue figures for the three months to the end of September represent a 17% increase on the US$2.08 million reported for the previous corresponding period. The result was fuelled […]
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.